A comparison of biofluid cytokine markers across platform technologies: Correspondence or divergence?
- PMID: 29908923
- PMCID: PMC6289877
- DOI: 10.1016/j.cyto.2018.05.032
A comparison of biofluid cytokine markers across platform technologies: Correspondence or divergence?
Abstract
Background: Quantification of biofluid cytokines is a rapidly growing area of translational research. However, comparability across the expanding number of available assay platforms for detection of the same proteins remains to be determined. We aimed to directly compare a panel of commonly measured cytokines in plasma of typically aging adults across two high sensitivity quantification platforms, Meso Scale Discovery high performance electrochemiluminiscence (HPE) and single-molecule immunosorbent assays (Simoa) by Quanterix.
Methods: 57 community-dwelling older adults completed a blood draw, neuropsychological assessment, and brain MRI as part of a healthy brain aging study. Plasma samples from the same draw dates were analyzed for IL-10, IP-10, IL-6, TNFα, and IL-1β on HPE and Simoa, separately. Reliable detectability (coefficient of variance (CV) < 20% and outliers 3 interquartiles above the median removed), intra-assay precision, absolute concentrations, reproducibility across platforms, and concurrent associations with external variables of interest (e.g., demographics, peripheral markers of vascular health, and brain health) were examined.
Results: The proportion of cytokines reliably measured on HPE (87.7-93.0%) and Simoa (75.4-93.0%) did not differ (ps > 0.32), with the exception of IL-1β which was only reliably measured using Simoa (68.4%). On average, CVs were acceptable at <8% across both platforms. Absolute measured concentrations were higher using Simoa for IL-10, IL-6, and TNFα (ps < 0.05). HPE and Simoa shared only small-to-moderate proportions of variance with one another on the same cytokine proteins (range: r = 0.26 for IL-10 to r = 0.64 for IL-6), though platform agreement did not dependent on cytokine concentrations. Cytokine ratios within each platform demonstrated similar relative patterns of up- and down-regulation across HPE and Simoa, though still significantly differed (ps < 0.001). Supporting concurrent validity, all 95% confidence intervals of the correlations between cytokines and external variables overlapped between the two platforms. Moreover, most associations were in expected directions and consistently so across platforms (e.g., IL-6 and TNFα), though with several notable exceptions for IP-10 and IL-10.
Conclusions: HPE and Simoa showed comparable detectability and intra-assay precision measuring a panel of commonly examined cytokine proteins, with the exception of IL-1β which was not reliably detected on HPE. However, Simoa demonstrated overall higher concentrations and the two platforms did not show agreement when directly compared against one another. Relative cytokine ratios and associations demonstrated similar patterns across platforms. Absolute cytokine concentrations may not be directly comparable across platforms, may be analyte dependent, and interpretation may be best limited to discussion of relative associations.
Keywords: Immune activation; Meso Scale Discovery; Plasma markers; Quanterix; Typical aging.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Figures






Similar articles
-
Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson's disease.Cytokine X. 2020 Apr 28;2(2):100027. doi: 10.1016/j.cytox.2020.100027. eCollection 2020 Jun. Cytokine X. 2020. PMID: 33604555 Free PMC article.
-
Measurement of IL-21 in human serum and plasma using ultrasensitive MSD S-PLEX® and Quanterix SiMoA methodologies.J Immunol Methods. 2019 Mar;466:9-16. doi: 10.1016/j.jim.2018.12.005. Epub 2018 Dec 24. J Immunol Methods. 2019. PMID: 30590020
-
Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum.J Immunol Methods. 2016 Oct;437:53-63. doi: 10.1016/j.jim.2016.08.003. Epub 2016 Aug 21. J Immunol Methods. 2016. PMID: 27555238
-
Ultrasensitive assay technology and fluid biomarkers for the evaluation of peripheral nerve disease.J Neurol Neurosurg Psychiatry. 2024 Jan 11;95(2):114-124. doi: 10.1136/jnnp-2023-332031. J Neurol Neurosurg Psychiatry. 2024. PMID: 37821222 Review.
-
Advances in single molecule arrays (SIMOA) for ultra-sensitive detection of biomolecules.Talanta. 2024 Apr 1;270:125529. doi: 10.1016/j.talanta.2023.125529. Epub 2023 Dec 10. Talanta. 2024. PMID: 38091745 Review.
Cited by
-
Systemic Tumor Necrosis Factor-Alpha Trajectories Relate to Brain Health in Typically Aging Older Adults.J Gerontol A Biol Sci Med Sci. 2020 Jul 13;75(8):1558-1565. doi: 10.1093/gerona/glz209. J Gerontol A Biol Sci Med Sci. 2020. PMID: 31549145 Free PMC article.
-
Investigation of Inflammation in Lewy Body Dementia: A Systematic Scoping Review.Int J Mol Sci. 2023 Jul 28;24(15):12116. doi: 10.3390/ijms241512116. Int J Mol Sci. 2023. PMID: 37569491 Free PMC article.
-
Comparison of highly sensitive, multiplex immunoassay platforms for streamlined clinical cytokine quantification.Bioanalysis. 2025 Jan;17(1):17-29. doi: 10.1080/17576180.2024.2442190. Epub 2024 Dec 20. Bioanalysis. 2025. PMID: 39703153
-
Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic Carriers.Eur J Neurol. 2025 Jun;32(6):e70215. doi: 10.1111/ene.70215. Eur J Neurol. 2025. PMID: 40462552 Free PMC article.
-
Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease Stage.J Alzheimers Dis. 2020;78(1):265-276. doi: 10.3233/JAD-200755. J Alzheimers Dis. 2020. PMID: 32986672 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources